we want you dead, broke & scammed

if you wish to treat alzheimer's safely 

take metformin after you have contemplated the available reading material and formulated your questions and obtained answers

Note the patents if any covering the below antibody

ask peter davies about all the possible sites in the body where the sntibody will bind

examine the financial agrrements between the parties

note newsday's failure to reference the trial  eg clinicaltrials.gov

living tissues have an energy producing. mechanism(s)

place your bets here against lilly snd nirthwell and their official purveyor of propaganda newsday

Hope in Alzheimer's fight is found in antibody developed on LI

Feinstein Institute for Medical Research scientists in Manhasset developed a protein antibody that is the basis of an experimental medication now being studied.

Alzheimer's researcher Dr. Peter Davies works at the Feinstein Institute on Aug. 30. Photo Credit: Michael Owens 

By Delthia Ricksdelthia.ricks@newsday.comUpdated November 11, 2018 6:00 AM

PRINT SHARE 

Despite billions of dollars and decades spent on Alzheimer’s research, medical scientists still haven’t found a cure, but a designer molecule developed on Long Island may pave the way to a new form of treatment.

Medical scientists at the Feinstein Institute for Medical Research in Manhasset have developed a protein antibody that is the basis of an experimental medication now under study.

The drug developed from it is so new, said renowned Alzheimer’s researcher Dr. Peter Davies, it's known only by letters and numbers: LY3303560. It is being tested in a clinical trial sponsored by pharmaceutical giant Eli Lilly, which is producing it.